McClarren Financial Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-16
Closed -$1K – 375
2023
Q2
$1K Sell
16
-11
-41% -$947 ﹤0.01% 316
2023
Q1
$1K Hold
27
– – ﹤0.01% 306
2022
Q4
$2K Buy
27
+6
+29% +$486 ﹤0.01% 298
2022
Q3
$1K Buy
+21
New +$1.89K ﹤0.01% 289
2022
Q2
– Sell
-20
Closed -$2K – 168
2022
Q1
$2K Sell
20
-2
-9% -$211 ﹤0.01% 254
2021
Q4
$3K Buy
22
+2
+10% +$232 ﹤0.01% 281
2021
Q3
$2K Hold
20
– – ﹤0.01% 259
2021
Q2
$2K Hold
20
– – ﹤0.01% 282
2021
Q1
$2K Hold
20
– – ﹤0.01% 240
2020
Q4
$2K Buy
+20
New +$2.2K ﹤0.01% 203

Other funds holding MDT

McClarren Financial Advisors's MDT Position: Q3 2023 in Review

McClarren Financial Advisors sold out of Medtronic (MDT) in Q3 2023, closing a stake of 16 shares — an estimated $1K sold.

McClarren Financial Advisors first reported a position in MDT in Q4 2020 and held it in 10 quarters. The position peaked at $3K in Q4 2021. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • McClarren Financial Advisors reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • McClarren Financial Advisors sold 16 Medtronic shares in Q3 2023, an estimated $1K.
  • McClarren Financial Advisors first reported a position in Medtronic in Q4 2020 and held it in 10 quarters.
  • McClarren Financial Advisors's Medtronic position peaked at $3K in Q4 2021.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on McClarren Financial Advisors's 13F filing for Q3 2023, filed 6 Nov 2023.